Finepoint Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNDA
Concord Acquisition Corp II
CNDA
|
+$12M |
| 2 |
AFTR
AfterNext HealthTech Acquisition Corp
AFTR
|
+$10.7M |
| 3 |
IVCPU
Swiftmerge Acquisition Corp. Unit
IVCPU
|
+$9.72M |
| 4 |
CPAA
Conyers Park III Acquisition Corp. Class A Common Stock
CPAA
|
+$8.84M |
| 5 |
CPAAW
Conyers Park III Acquisition Corp. Warrants
CPAAW
|
+$571K |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 88.06% |
| 2 | Healthcare | 4.98% |
| 3 | Consumer Discretionary | 0% |
Similar funds
Finepoint Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Finepoint Capital held 87 positions worth $390M, down 33% from $586M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Finepoint Capital withdrew a net $195M in Q4 2021, closing 16 positions and reducing 6 holdings. Its most notable exit was Spartan Acquisition Corp. III, an estimated $18.6M position sold in full.
By sector, the portfolio is most concentrated in Financials at 88% of assets, up from 71% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Finepoint Capital opened a new position in Concord Acquisition Corp II worth $11.9M.
- Finepoint Capital's largest Q4 2021 buy was Concord Acquisition Corp II: 1,225,000 shares worth $11.9M.
- Finepoint Capital's biggest Q4 2021 reduction was Churchill Capital Corp VII Class A Common Stock, cutting an estimated $9.8M.
- Finepoint Capital fully exited Spartan Acquisition Corp. III in Q4 2021, selling an estimated $18.6M.
- Finepoint Capital's ten largest holdings make up 47% of its $390M portfolio in Q4 2021.
- Finepoint Capital opened 13 new positions and closed 16 in Q4 2021.
- Finepoint Capital's portfolio value fell 33% quarter-over-quarter to $390M.
Based on Finepoint Capital's 13F filing for Q4 2021, filed 11 Feb 2022.